Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Mobile Health Monitoring in Patients with Idiopathic Pulmonary Fibrosis.

Marcoux V, Wang M, Burgoyne SJ, Fell CD, Ryerson CJ, Sajobi TT, Johannson KA.

Ann Am Thorac Soc. 2019 Jun 26. doi: 10.1513/AnnalsATS.201904-335RL. [Epub ahead of print] No abstract available.

PMID:
31242394
2.

Diagnostic Likelihood Thresholds that Define a Working Diagnosis of Idiopathic Pulmonary Fibrosis.

Walsh SLF, Lederer DJ, Ryerson CJ, Kolb M, Maher TM, Nusser R, Poletti V, Richeldi L, Vancheri C, Wilsher ML, Antoniou KM, Behr J, Bendstrup E, Brown KK, Corte TJ, Cottin V, Crestani B, Flaherty KR, Glaspole IN, Grutters J, Inoue Y, Kondoh Y, Kreuter M, Johannson KA, Ley B, Martinez FJ, Molina-Molina M, Morais A, Nunes H, Raghu G, Selman M, Spagnolo P, Taniguchi H, Tomassetti S, Valeyre D, Wijsenbeek M, Wuyts WA, Wells AU.

Am J Respir Crit Care Med. 2019 Jun 26. doi: 10.1164/rccm.201903-0493OC. [Epub ahead of print]

3.

Autoantibody status is not associated with change in lung function or survival in patients with idiopathic pulmonary fibrosis.

Goobie GC, Ford-Sahibzada CA, Fritzler MJ, Johannson KA, Fell CD.

Respir Med. 2019 Jul;153:85-90. doi: 10.1016/j.rmed.2019.05.019. Epub 2019 May 29.

PMID:
31176275
4.

Oxygen in patients with fibrotic interstitial lung disease: an international Delphi survey.

Lim RK, Humphreys C, Morisset J, Holland AE, Johannson KA.

Eur Respir J. 2019 Aug 8;54(2). pii: 1900421. doi: 10.1183/13993003.00421-2019. Print 2019 Aug.

PMID:
31097522
5.

Costs of Workplace Productivity Loss in Patients With Fibrotic Interstitial Lung Disease.

Algamdi M, Sadatsafavi M, Fisher JH, Morisset J, Johannson KA, Fell CD, Kolb M, Manganas H, Cox G, Gershon AS, Halayko AJ, Hambly N, Khalil N, Shapera S, To T, Wilcox PG, Guler S, Ryerson CJ.

Chest. 2019 Apr 30. pii: S0012-3692(19)30885-2. doi: 10.1016/j.chest.2019.04.016. [Epub ahead of print]

6.

YouTube Videos as a Source of Misinformation on Idiopathic Pulmonary Fibrosis.

Goobie GC, Guler SA, Johannson KA, Fisher JH, Ryerson CJ.

Ann Am Thorac Soc. 2019 May;16(5):572-579. doi: 10.1513/AnnalsATS.201809-644OC.

PMID:
30608877
7.

Response.

Johannson KA, Vittinghoff E, Morisset J, Wolters PJ, Noth EM, Balmes JR, Collard HR.

Chest. 2018 Sep;154(3):727-728. doi: 10.1016/j.chest.2018.05.042. No abstract available.

PMID:
30195362
8.

That's a WRAP: laparoscopic anti-reflux surgery for idiopathic pulmonary fibrosis.

Johannson KA.

Lancet Respir Med. 2018 Sep;6(9):655-657. doi: 10.1016/S2213-2600(18)30330-8. Epub 2018 Aug 9. No abstract available.

PMID:
30100405
9.

Contralateral recurrence of inflammatory myofibroblastic tumour of the lung 10 years after pneumonectomy.

Vis DC, Kelly MM, Lee AG, Gelfand G, Johannson KA.

Thorax. 2018 Nov;73(11):1089-1090. doi: 10.1136/thoraxjnl-2018-211645. Epub 2018 Jun 8. No abstract available.

PMID:
29884625
10.

Impact of processing technique on bronchoalveolar lavage cellular analysis.

Barss L, Fraser KL, Kelly MM, Johannson KA.

Eur Respir J. 2018 Mar 29;51(3). pii: 1701769. doi: 10.1183/13993003.01769-2017. Print 2018 Mar. No abstract available.

PMID:
29599116
11.

Air Pollution Exposure Is Associated With Lower Lung Function, but Not Changes in Lung Function, in Patients With Idiopathic Pulmonary Fibrosis.

Johannson KA, Vittinghoff E, Morisset J, Wolters PJ, Noth EM, Balmes JR, Collard HR.

Chest. 2018 Jul;154(1):119-125. doi: 10.1016/j.chest.2018.01.015. Epub 2018 Feb 7.

12.

Oxygen Prescription in Interstitial Lung Disease: 2.5 Billion Years in the Making.

Morisset J, Ryerson CJ, Johannson KA.

Ann Am Thorac Soc. 2017 Dec;14(12):1755-1756. doi: 10.1513/AnnalsATS.201708-675ED. No abstract available.

PMID:
29192812
13.

Identification of Diagnostic Criteria for Chronic Hypersensitivity Pneumonitis: An International Modified Delphi Survey.

Morisset J, Johannson KA, Jones KD, Wolters PJ, Collard HR, Walsh SLF, Ley B; HP Delphi Collaborators.

Am J Respir Crit Care Med. 2018 Apr 15;197(8):1036-1044. doi: 10.1164/rccm.201710-1986OC. Epub 2017 Nov 27.

14.

Air pollution exposure and IPF: prevention when there is no cure.

Johannson KA.

Thorax. 2018 Feb;73(2):103-104. doi: 10.1136/thoraxjnl-2017-210808. Epub 2017 Nov 3. No abstract available.

PMID:
29101283
15.

Palliative care in interstitial lung disease: living well.

Kreuter M, Bendstrup E, Russell AM, Bajwah S, Lindell K, Adir Y, Brown CE, Calligaro G, Cassidy N, Corte TJ, Geissler K, Hassan AA, Johannson KA, Kairalla R, Kolb M, Kondoh Y, Quadrelli S, Swigris J, Udwadia Z, Wells A, Wijsenbeek M.

Lancet Respir Med. 2017 Dec;5(12):968-980. doi: 10.1016/S2213-2600(17)30383-1. Epub 2017 Oct 13. Review.

16.

Home monitoring improves endpoint efficiency in idiopathic pulmonary fibrosis.

Johannson KA, Vittinghoff E, Morisset J, Lee JS, Balmes JR, Collard HR.

Eur Respir J. 2017 Jul 5;50(1). pii: 1602406. doi: 10.1183/13993003.02406-2016. Print 2017 Jul.

17.

Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers?

Johannson KA, Strâmbu I, Ravaglia C, Grutters JC, Valenzuela C, Mogulkoc N, Luppi F, Richeldi L, Wells AU, Vancheri C, Kreuter M; Erice ILD Working Group.

Lancet Respir Med. 2017 Jul;5(7):591-598. doi: 10.1016/S2213-2600(17)30219-9. Review.

PMID:
28664861
18.

Supplemental Oxygen in Interstitial Lung Disease: An Art in Need of Science.

Johannson KA, Pendharkar SR, Mathison K, Fell CD, Guenette JA, Kalluri M, Kolb M, Ryerson CJ.

Ann Am Thorac Soc. 2017 Sep;14(9):1373-1377. doi: 10.1513/AnnalsATS.201702-137OI.

PMID:
28644693
19.

Pathologic Findings and Prognosis in a Large Prospective Cohort of Chronic Hypersensitivity Pneumonitis.

Wang P, Jones KD, Urisman A, Elicker BM, Urbania T, Johannson KA, Assayag D, Lee J, Wolters PJ, Collard HR, Koth LL.

Chest. 2017 Sep;152(3):502-509. doi: 10.1016/j.chest.2017.02.011. Epub 2017 Feb 20.

PMID:
28223152
20.

The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumonia.

Brownell R, Moua T, Henry TS, Elicker BM, White D, Vittinghoff E, Jones KD, Urisman A, Aravena C, Johannson KA, Golden JA, King TE Jr, Wolters PJ, Collard HR, Ley B.

Thorax. 2017 May;72(5):424-429. doi: 10.1136/thoraxjnl-2016-209671. Epub 2017 Jan 12.

21.

Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity Pneumonitis.

Morisset J, Johannson KA, Vittinghoff E, Aravena C, Elicker BM, Jones KD, Fell CD, Manganas H, Dubé BP, Wolters PJ, Collard HR, Ryerson CJ, Ley B.

Chest. 2017 Mar;151(3):619-625. doi: 10.1016/j.chest.2016.10.029. Epub 2016 Nov 3.

22.

Validity of administrative data for identification of obstructive sleep apnea.

Laratta CR, Tsai WH, Wick J, Pendharkar SR, Johannson KA, Ronksley PE.

J Sleep Res. 2017 Apr;26(2):132-138. doi: 10.1111/jsr.12465. Epub 2016 Oct 20.

23.

What Gets Measured Gets Managed: Daily Home Spirometry in Idiopathic Pulmonary Fibrosis.

Johannson KA, Ryerson CJ.

Am J Respir Crit Care Med. 2016 Oct 15;194(8):926-927. No abstract available.

PMID:
27739884
24.

Diagnostic Yield and Complications of Transbronchial Lung Cryobiopsy for Interstitial Lung Disease. A Systematic Review and Metaanalysis.

Johannson KA, Marcoux VS, Ronksley PE, Ryerson CJ.

Ann Am Thorac Soc. 2016 Oct;13(10):1828-1838. Review.

PMID:
27466899
25.

The Canadian Registry for Pulmonary Fibrosis: Design and Rationale of a National Pulmonary Fibrosis Registry.

Ryerson CJ, Tan B, Fell CD, Manganas H, Shapera S, Mittoo S, Sadatsafavi M, To T, Gershon A, Fisher JH, Johannson KA, Hambly N, Khalil N, Marras TK, Morisset J, Wilcox PG, Halayko AJ, Khan MA, Kolb M.

Can Respir J. 2016;2016:3562923. doi: 10.1155/2016/3562923. Epub 2016 Apr 5.

26.

High Oxygen Delivery to Preserve Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib. Methodology of the HOPE-IPF Study.

Ryerson CJ, Camp PG, Eves ND, Schaeffer M, Syed N, Dhillon S, Jensen D, Maltais F, O'Donnell DE, Raghavan N, Roman M, Stickland MK, Assayag D, Bourbeau J, Dion G, Fell CD, Hambly N, Johannson KA, Kalluri M, Khalil N, Kolb M, Manganas H, Morán-Mendoza O, Provencher S, Ramesh W, Rolf JD, Wilcox PG, Guenette JA.

Ann Am Thorac Soc. 2016 Sep;13(9):1640-7. doi: 10.1513/AnnalsATS.201604-267OC.

PMID:
27348402
27.

A diagnostic model for chronic hypersensitivity pneumonitis.

Johannson KA, Elicker BM, Vittinghoff E, Assayag D, de Boer K, Golden JA, Jones KD, King TE Jr, Koth LL, Lee JS, Ley B, Wolters PJ, Collard HR.

Thorax. 2016 Oct;71(10):951-4. doi: 10.1136/thoraxjnl-2016-208286. Epub 2016 May 31.

28.

The CAnadian REgistry for Pulmonary Fibrosis (CARE-PF): Design and rationale of a national pulmonary fibrosis registry.

Ryerson CJ, Tan B, Fell CD, Manganas H, Shapera S, Mittoo S, Sadatsafavi M, To T, Gershon A, Fisher JH, Johannson KA, Hambly N, Khalil N, Marras TK, Morisset J, Wilcox PG, Halayko AJ, Khan MA, Kolb M.

Can Respir J. 2015 Nov 2. pii: 17206. [Epub ahead of print] No abstract available.

PMID:
26523546
29.

Models of disease behavior in idiopathic pulmonary fibrosis.

Johannson KA, Ley B, Collard HR.

BMC Med. 2015 Sep 24;13:165. doi: 10.1186/s12916-015-0403-7.

30.

Air pollution exposure: a novel environmental risk factor for interstitial lung disease?

Johannson KA, Balmes JR, Collard HR.

Chest. 2015 Apr;147(4):1161-1167. doi: 10.1378/chest.14-1299. Review.

31.

Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT.

Johannson KA, de Boer K, Wolters PJ, Golden JA, Lee JS, Collard HR.

Lancet Respir Med. 2014 May;2(5):e5. doi: 10.1016/S2213-2600(14)70075-X. No abstract available.

PMID:
24815808
32.

Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure.

Johannson KA, Vittinghoff E, Lee K, Balmes JR, Ji W, Kaplan GG, Kim DS, Collard HR.

Eur Respir J. 2014 Apr;43(4):1124-31. doi: 10.1183/09031936.00122213. Epub 2013 Oct 31.

33.

Cryptococcus gattii pneumonia.

Johannson KA, Huston SM, Mody CH, Davidson W.

CMAJ. 2012 Sep 4;184(12):1387-90. doi: 10.1503/cmaj.111346. Epub 2012 Aug 13. No abstract available.

Supplemental Content

Loading ...
Support Center